© 2026 Buobe

EMBL spin-off Epitome Therapeutics launches to advance precision epigenome editing | Buobe

EMBL spin-off Epitome Therapeutics launches to advance precision epigenome editing

Published by

on •1 min read

EMBL spin-off Epitome Therapeutics launches to advance precision epigenome editing

A newly launched EMBL spin-off, Epitome Therapeutics, aims to translate pioneering research in epigenome editing into a new generation of precision medicines.

precision medicine epigenome editing spin-off